Rothenberg CURED Research Lab Videos
The Rothenberg CURED Research Lab is an active member of research, professional and patient advocacy communities for allergic and eosinophilic conditions, as represented in the following videos.
Rothenberg CURED Lab | Video Resources,
Journey to the First FDA Approved Drug for EoE (2022)
"Eosinophilic Gastrointestinal Disorders (EGID): Clinical Trial Update In View of Recent 2022 Data (2022)"
Journey to the First FDA-approved Drug for Eosinophilic Esophagitis (September 2022)
The Cincinnati Center for Eosinophilic Disorders
2021 Research Highlights: Division of Allergy and Immunology (May 2022)
Marc E. Rothenberg, MD, PhD, Scholar Day Mentoring Talk (2022)
Applying for the NIH Loan Repayment Program (2021)
Bridge to Next-Gen Medicine: Improving Pediatric Medicine on a Global Scale (2021).
2020 Research Highlights: Division of Allergy and Immunology (February 2021)
“The CURED” – 5th CURED EGID Research Conference and Patient Education Program (November 2019)
Qué es la esofagitis eosinofílica?
FDA-approved Drug Reverses Inflammation in Experimental Food Allergic Disease of the Esophagus (May 2020)
Food Allergy Fund Summit: “How COVID is Stimulating New Ideas that Benefit Food Allergies with Particular Focus on Eosinophilic Esophagitis” (May 2020)
Anti-IL-13 Phase 2 Trial for Eosinophilic Esophagitis (November 2018)
Absence of Key Protein, SPINK7, May Drive Eosinophilic Esophagitis (June 2018)
Select Research Advances of 2017: Division of Allergy and Immunology (January 2018)
What is eosinophilic esophagitis?
Research Advances: Division of Allergy and Immunology (June 2020)
Creating EGIDExpress (May 2020)
A Message from CEGIR: COVID-19 (March 2020)
Select Research Advances of 2018: Division of Allergy and Immunology (January 2019)
AGREE Conference: Proton Pump Inhibitors and Eosinophilic Esophagitis (August 2018)
Identification of Genes Associated with Eosinophilic Esophagitis (April 2018)
4th CURED EGID Research Conference and Patient Education Program (November 2017)
2017 End of Year Message: Rothenberg on the Causes and Research Pipeline of Eosinophilic Esophagitis (December 2017)
Select Research Advances of 2016: Division of Allergy and Immunology (January 2017)
Select Research Advances of 2015 and early 2016
2016 End of Year Message (January 2017)
Contact Registry Video Project (July 2015)
2015 End of Year Message (November 2015)
2014 End of Year Message (December 2014)
Current Projects
Learn more about the areas of research and current projects of the Rothenberg CURED Research Laboratory.
Read More
Learn more about the Cincinnati Center for Eosinophilic Disorders on the Cincinnati Children’s blog.
Read MoreResearch Science Blog
Learn more about research efforts on eosinophilic conditions, including news and insights about the latest discoveries and innovations developed by the scientists of Cincinnati Children’s.
Read the Blog
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
© 1999-2022 Cincinnati Children's Hospital Medical Center. All rights reserved.
